Arzerra

List of products in the National Drug Code with proprietary name arzerra. Ofatumumab is used to treat a certain type of cancer (chronic lymphocytic leukemia - CLL). Ofatumumab belongs to a class of drugs known as monoclonal antibodies. This medication works by stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0078-0669Arzerra OfatumumabInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0690Arzerra OfatumumabInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug